Web暨南大学,数字图书馆. 开馆时间:周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 WebAfter siRNA transfection was conducted by cartilage-targeting nanoparticles, the protein levels of Hif-2α, matrix metalloproteinases (MMP-13, -9), a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS-4, -5), vascular endothelial growth factor (VEGF), type X collagen and nuclear factor (NF)-κB in interleukin-1-beta (IL-1β)-stimulated …
(PDF) STAT3 and HIF1 alpha cooperatively activate HIF1 target genes …
Web10 de set. de 2012 · USF2 siRNA reduces HIF2 but not HIF1 target gene expression in normoxic RCC4 cells. (A) qPCR analysis of HIF1 ␣ , HIF2 ␣ , and USF2 mRNA in … WebEffects of siRNA-GLUT-1 and LY294002 on apoptosis and cell cycle in Hep-2 cells after treatment with cisplatinBefore the cisplatin treatment, the apoptotic rates of cells in the siRNA-GLUT-1 and LY294002 groups were increased markedly at 24 hours and 48 hours compared with the Hep-2 cell and siRNA-NC groups (P<0.05; Figure 2).The early … five shilling coin 1977
(PDF) USF2 and HIF2α cooperatively activate HIF2 target …
Web1 de out. de 2024 · ARO-HIF2: siRNA: TRiM™ formulation: ... While siRNA and mRNA candidates are the most abundant, dozens of other RNA therapeutic candidates have also entered clinical trials (Table 1). Indeed, four RNA-based ASOs are currently under clinical investigation: QR-010, QR-421a, QR-1123, and QR110, all developed by ProQR. WebsiRNA products generally consist of pools of three to five target-specific 19-25 nt siRNAs designed to knockdown gene expression; for independent verification of EPAS-1/HIF-2 alpha gene silencing results, individual siRNA duplex components are also available upon request; suitable control antibody: EPAS-1/HIF-2 alpha Antibody (190b): sc-13596 WebARO-HIF2 is composed of HIF2 siRNA targeting HIF2α and uses a proprietary targeted-RNAi molecule (TRiM) delivery platform, which comprises targeting ligands, such as RGD motifs designed to transport siRNA to cancer cells. ARO-HIF2 use resulted in HIF2α mRNA knockdown, tumor growth inhibition, and OS improvement in a xenograft model of clear ... five shifts at toms 3